Search alternatives:
gap decrease » gain decreased (Expand Search), step decrease (Expand Search), _ decrease (Expand Search)
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), teer decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
gap decrease » gain decreased (Expand Search), step decrease (Expand Search), _ decrease (Expand Search)
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), teer decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
4181
Table 1_Identification of potential miRNA biomarkers for neurobrucellosis diagnosis.xlsx
Published 2025“…Additionally, RT-qPCR results revealed decreased levels of VAV3 (vav guanine nucleotide exchange factor 3, a target of miR-499a-5p) and IGF1 (insulin like growth factor 1, a target of miR-576-5p) in the CSF samples of NB patients.…”
-
4182
Table 3_Identification of potential miRNA biomarkers for neurobrucellosis diagnosis.xlsx
Published 2025“…Additionally, RT-qPCR results revealed decreased levels of VAV3 (vav guanine nucleotide exchange factor 3, a target of miR-499a-5p) and IGF1 (insulin like growth factor 1, a target of miR-576-5p) in the CSF samples of NB patients.…”
-
4183
Table 4_Identification of potential miRNA biomarkers for neurobrucellosis diagnosis.xlsx
Published 2025“…Additionally, RT-qPCR results revealed decreased levels of VAV3 (vav guanine nucleotide exchange factor 3, a target of miR-499a-5p) and IGF1 (insulin like growth factor 1, a target of miR-576-5p) in the CSF samples of NB patients.…”
-
4184
Table 2_Identification of potential miRNA biomarkers for neurobrucellosis diagnosis.xlsx
Published 2025“…Additionally, RT-qPCR results revealed decreased levels of VAV3 (vav guanine nucleotide exchange factor 3, a target of miR-499a-5p) and IGF1 (insulin like growth factor 1, a target of miR-576-5p) in the CSF samples of NB patients.…”
-
4185
Data Sheet 1_Identification of potential miRNA biomarkers for neurobrucellosis diagnosis.pdf
Published 2025“…Additionally, RT-qPCR results revealed decreased levels of VAV3 (vav guanine nucleotide exchange factor 3, a target of miR-499a-5p) and IGF1 (insulin like growth factor 1, a target of miR-576-5p) in the CSF samples of NB patients.…”
-
4186
Table 6_Identification of potential miRNA biomarkers for neurobrucellosis diagnosis.xlsx
Published 2025“…Additionally, RT-qPCR results revealed decreased levels of VAV3 (vav guanine nucleotide exchange factor 3, a target of miR-499a-5p) and IGF1 (insulin like growth factor 1, a target of miR-576-5p) in the CSF samples of NB patients.…”
-
4187
Table 5_Identification of potential miRNA biomarkers for neurobrucellosis diagnosis.xlsx
Published 2025“…Additionally, RT-qPCR results revealed decreased levels of VAV3 (vav guanine nucleotide exchange factor 3, a target of miR-499a-5p) and IGF1 (insulin like growth factor 1, a target of miR-576-5p) in the CSF samples of NB patients.…”
-
4188
-
4189
-
4190
-
4191
-
4192
Unraveling the Mechanism of 1‑Deoxynojirimycin (DNJ) Accumulation: The Role of SWEET3 in Mulberry Chloroplasts
Published 2025“…Here, we visualized DNJ localization using a fluorescent probe and found that DNJ predominantly accumulates in the chloroplasts of mulberry leaves but not in callus tissue. …”
-
4193
-
4194
Global Land Use Change Impacts on Soil Nitrogen Availability and Environmental Losses
Published 2025“…However, how global land use changes impact soil N supply and potential N loss remains elusive. By compiling a global data set of 1,782 paired observations from 185 publications, we show that land use conversion from natural to managed ecosystems significantly reduced NNM by 7.5% (−11.5, −2.8%) and increased NN by 150% (86, 194%), indicating decreasing N availability while increasing potential N loss through denitrification and nitrate leaching. …”
-
4195
-
4196
-
4197
PRISMA flowchart of the included studies.
Published 2025“…On the other hand, patients in the immunotherapy group had significantly decreased HbA1c levels (MD = -0.63; 95% CI: [-1.18, -0.07]; p = 0.03), indicating that immunotherapy had a positive impact on glycemic management. …”
-
4198
Characteristics of Included Studies.
Published 2025“…On the other hand, patients in the immunotherapy group had significantly decreased HbA1c levels (MD = -0.63; 95% CI: [-1.18, -0.07]; p = 0.03), indicating that immunotherapy had a positive impact on glycemic management. …”
-
4199
-
4200